Startups
Asgard Therapeutics
https://asgardthx.comDeveloper of vivo direct cell reprogramming for cancer immunotherapy.
Summary
Industry
Investors
- Industrifonden Series A
- Novo A/S Series A
- Novo A/S Series A
- Boehringer Ingelheim Venture Fund Series A
- Johnson & Johnson Series A
- Industrifonden Seed
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable